OrganOx secures $142m to transform organ transplantation

OrganOx, a pioneer in medical technology revolutionizing organ transplantation, has successfully closed a $142m equity investment, led by Lauxera Capital Partners, BGF, and HealthQuest Capital.

With over 5,000 liver transplants supported using its technology, OrganOx has reduced liver discards by 50% and enabled a 20% increase in success fultransplants compared to traditional cold storage methods.

This funding milestone will accelerate OrganOx’s expansion and further solidify its leadership in the transplantation industry. We are proud to support this visionary company alongside its investors and management team.